Search

everythinglearnresearchcommunity

for

Search:↓

The new drug delivery system effectively targets lung cancer cells.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Doxorubicin can block blood vessels from hair follicles, reducing skin tumor growth.

Proton minibeam radiotherapy may reduce skin side effects by causing localized DNA damage.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Puerariae Radix extract may be a promising cosmetic ingredient for skin health.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

EGFR inhibitors often cause dry, brittle hair and eyebrow/eyelash changes.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Prostaglandin helps regenerate hair follicles after radiation damage.

New cancer drugs often cause skin and nail problems.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Minoxidil helps prevent hair loss from chemotherapy in rats.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.